BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29123267)

  • 1. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
    Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
    Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.
    Wei F; Tang L; He Y; Wu Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Ni Q; Luo J; Li X; Li Y; Peng C; Chen X; Li G; Xiong W; Zeng Z
    Cell Death Dis; 2018 Apr; 9(4):432. PubMed ID: 29568064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.
    He JY; Han P; Zhang Y; Liu YD; Song SJ; Feng GK; An Y; Zhou AJ; Wang HB; Yuan L; Lin ZR; Xia TL; Li MZ; Liu YM; Huang XM; Zhang H; Zhong Q
    J Mol Med (Berl); 2018 Apr; 96(3-4):265-279. PubMed ID: 29327067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma.
    Jiang X; Deng X; Wang J; Mo Y; Shi L; Wei F; Zhang S; Gong Z; He Y; Xiong F; Wang Y; Guo C; Xiang B; Zhou M; Liao Q; Li X; Li Y; Li G; Xiong W; Zeng Z
    Oncogene; 2022 Jan; 41(2):233-245. PubMed ID: 34725462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
    Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
    PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
    Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
    Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.
    Yuan J; Chen L; Xiao J; Qi XK; Zhang J; Li X; Wang Z; Lian YF; Xiang T; Zhang Y; Chen MY; Bei JX; Zeng YX; Feng L
    Cell Death Dis; 2019 Jan; 10(2):58. PubMed ID: 30683844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
    Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
    Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug/vimentin but not snail in nasopharyngeal carcinoma: Inhibition of EMT in vitro and in vivo in mice.
    Wang W; Li X; Zhang W; Li W; Yi M; Yang J; Zeng Z; Colvin Wanshura LE; McCarthy JB; Fan S; Zheng P; Chen S; Xiang B; Li G
    Cancer Lett; 2014 Jun; 348(1-2):109-18. PubMed ID: 24657653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
    Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown Rab11-FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling.
    Feng G; Qin L; Liao Z; Xiao X; Li B; Cui W; Liang L; Mo Y; Huang G; Li P; Zhou X; Zhang Z; Xiao X
    J Cell Biochem; 2020 Feb; 121(2):1072-1086. PubMed ID: 31452257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.
    Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT
    Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pinosylvin inhibits migration and invasion of nasopharyngeal carcinoma cancer cells via regulation of epithelial‑mesenchymal transition and inhibition of MMP‑2.
    Chuang YC; Hsieh MC; Lin CC; Lo YS; Ho HY; Hsieh MJ; Lin JT
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.